Clinical Practice Guidelines

Cancer Screening Guidelines Need to Address Higher Risk in SOTRs

Cancer Screening Guidelines Need to Address Higher Risk in SOTRs

By

Solid organ transplant recipients (SOTRs) are 3 times more likely to develop cancer; however, clinical practice guidelines for cancer screening in this population do not reflect this increased risk.

Prevalence of Financial Conflicts of Interest Among Guideline Authors Is Significant

Prevalence of Financial Conflicts of Interest Among Guideline Authors Is Significant

By

Collaboration between physicians and industry is vital in developing effective cancer treatments; however, a new study reveals the potential for undue influence among guideline authors may be significant.

ASCO Updates the Development Process for Its Clinical Practice Guidelines

ASCO Updates the Development Process for Its Clinical Practice Guidelines

By

ASCO has laid out a game plan to set the stage for incorporating new therapies and approaches into clinical guidelines as quickly and accurately as possible.

Most US Cancer Prevention Guidelines Lack Information Needed for Care Decisions

Most US Cancer Prevention Guidelines Lack Information Needed for Care Decisions

By

Most US cancer prevention and screening recommendations do not provide adequate information for making informed care decisions.

ASCO Releases Resource-Stratified Guidelines for Management of Invasive Cervical Cancer

ASCO Releases Resource-Stratified Guidelines for Management of Invasive Cervical Cancer

By

ASCO has published its first clinical practice guideline on invasive cervical cancer, and the guidelines are the first to offer treatment recommendations tailored to resource availability.

Study Supports Increased Role for Surgery in Multimodality Therapy for Early Stage SCLC

Study Supports Increased Role for Surgery in Multimodality Therapy for Early Stage SCLC

By

Surgery for early stage small cell lung cancer (SCLC) is rarely used. However, results from a population-based database has shown surgery with adjuvant chemotherapy with or without radiation for node-negative SCLC was associated with better survival compared with concurrent chemoradiation, according to a presentation at the 2016 ASCO Annual Meeting.

Consensus Statement Guides Optimal Management of EGFR-Mutation-Positive NSCLC

Consensus Statement Guides Optimal Management of EGFR-Mutation-Positive NSCLC

By

The 2016 consensus statement from the International Association for the Study of Lung Cancer (IASLC) describes how to best manage EGFR-mutation-positive NSCLC.

Cancer Treatment and Prevention Guidelines Fall Short on Presenting Full Benefits and Harms

By

Most cancer prevention and screening recommendation statements fail to quantify benefits and harms or present them in an uneven manner, which might limit clinicians and patients in making informed decisions.

ASTRO Develops a Template to Facilitate Radiotherapy-Specific Cancer Survivorship Care Plans

ASTRO Develops a Template to Facilitate Radiotherapy-Specific Cancer Survivorship Care Plans

By

As the American College of Surgeons' Commision on Cancer milestones approach, ASTRO publishes a template to ensure consistent, comprehensive survivorship care plans can be developed for cancer survivors whose treatment involved radiotherapy.

New Guideline from ASCO Addresses Use of Biomarkers for Early Breast Cancer

By

A new clinical practice guideline on the appropriate use of tests for breast tumor biomarkers was issued by ASCO.

ACS and ASCO Release Their Survivorship Care Guidelines for Breast Cancer

American Cancer Society and American Society of Clinical Oncology publish their breast cancer survivorship care guideline, providing care guidance for the estimated 3.1 million female adult survivors of breast cancer in the United States.

New Guidelines for Managing Thyroid Nodules and Differentiated Thyroid Cancer in Adults

By

New, evidence-based recommendations from the American Thyroid Association will help guide the management of thyroid nodules. The new guidelines also focus on diagnosis and management of DTC, an increasingly prevalent form of cancer.

American Cancer Society releases survivorship care guidelines for colorectal cancer survivors

American Cancer Society releases survivorship care guidelines for colorectal cancer survivors

The American Cancer Society (ACS) has released its second in a series of cancer survivorship care guidelines.

Survivorship care plans: The shift back to primary care

Survivorship care plans: The shift back to primary care

By

New templates from the American Society of Clinical Oncology (ASCO) will augment successful cancer survivorship care planning. But a stronger effort toward implementation is still needed.

American College of Physicians (ACP) issues cancer screening advice for five common cancers

By

The American College of Physicians (ACP) has released updated guidance for screening average-risk adults without symptoms for breast, cervical, colorectal, ovarian, and prostate cancer.

Most surgeons disregard US Preventive Services Task Force (USPSTF) breast screening recommendation

By

A majority of surgeon continue to recommend annual breast cancer screening for women in their forties, despite a 2009 US Preventive Services Task Force (USPSTF) recommendation that recommends otherwise.

Smoking cessation: Helping patients with cancer quit

Smoking cessation: Helping patients with cancer quit

By

The NCCN Clinical Practice Guidelines in Oncology for Smoking Cessation can help you plan a successful quit program for your patients who smoke.

Treatment guidelines for pediatric Hodgkin lymphoma issued by the International Lymphoma Radiation Oncology Group (ILROG)

By

The International Lymphoma Radiation Oncology Group (ILROG) has issued a guideline outlining use of 3-D computed tomography (CT)-based radiation therapy planning.

Wide variation exists in the quality and content of clinical cancer guidelines

By

A review of top clinical guidelines for rectal cancer shows a variety of treatment recommendations.

Breast cancer prophylaxis updated

Breast cancer prophylaxis updated

Clinicians should discuss the prophylactic use of tamoxifen as well as two other agents with women 35 years and older and at increased risk of ER-positive breast cancer, per ASCO recommendations.

Trial results for cancer drugs often go unpublished

Trial results for cancer drugs often go unpublished

Results for almost half of U.S. cancer drug trials are still not available three years after study completion.

Guidelines cover diagnosis, staging of esophageal cancer

By

The Society of Thoracic Surgeons (STS) has released new clinical-practice guidelines that feature evidence-based recommendations to help clinicians diagnose and stage esophageal cancer.

New multiple myeloma treatment guidelines personalize therapy for patients

By

New guidelines have been developed to treat recently diagnosed multiple myeloma in patients who are not participating in clinical trials.

ASCO updates breast cancer follow-up guidelines

These guidelines are the first clinical practice guidelines issued by ASCO since 2006.

New colonoscopy schedule mirrors prior advice

Two of three main recommendations for colonoscopy surveillance are now supported by stronger evidence than they were in 2006.

The role of sunitinib in the treatment of GIST

The role of sunitinib in the treatment of GIST

What is the role of sunitinib malate in the treatment of sarcomas?

Radiation after lumpectomy might benefit older women after all

Most older women with early breast cancer are more likely to avoid mastectomy by following lumpectomy with radiation, contrary to current thinking.

Guidelines: screen for lung cancer with low-dose CT

The American Association for Thoracic Surgery wants annual lung cancer screening for 55-to-79-year-olds with a 30 pack-year history of smoking.

CT lung screening useful for some smokers, but drawbacks remain

Annual lung cancer screening with low-dose computed tomography may benefit some smokers, but uncertainty exists as to the harms of screening.

ACP issues new colorectal screening guidance

New guidelines call for screening at age 50 years in average-risk adults and age 40 years or 10 years younger than age of diagnosis in the youngest affected relative in high-risk adults.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs